News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,018 Results
Type
Article (86362)
Company Profile (651)
Press Release (758005)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232615)
Career Advice (4126)
Deals (39718)
Drug Delivery (129)
Drug Development (90932)
Employer Resources (198)
FDA (18077)
Job Trends (17330)
News (396293)
Policy (39729)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (92)
Alliances (56816)
ALS (98)
Alzheimer's disease (1493)
Antibody-drug conjugate (ADC) (150)
Approvals (18055)
Artificial intelligence (293)
Autoimmune disease (27)
Automation (16)
Bankruptcy (403)
Best Places to Work (12616)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (448)
Bladder cancer (81)
Brain cancer (30)
Breast cancer (292)
Cancer (2380)
Cardiovascular disease (199)
Career advice (3533)
Career pathing (34)
CAR-T (169)
Cell therapy (474)
Cervical cancer (20)
Clinical research (73318)
Collaboration (898)
Compensation (535)
Complete response letters (28)
COVID-19 (2861)
CRISPR (48)
C-suite (259)
Cystic fibrosis (106)
Data (2249)
Decentralized trials (2)
Denatured (45)
Depression (50)
Diabetes (279)
Diagnostics (6901)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (131)
Drug pricing (119)
Drug shortages (29)
Duchenne muscular dystrophy (100)
Earnings (96529)
Editorial (42)
Employer branding (25)
Employer resources (167)
Events (129820)
Executive appointments (753)
FDA (19363)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (791)
Gene editing (119)
Generative AI (26)
Gene therapy (352)
GLP-1 (829)
Government (5149)
Grass and pollen (5)
Guidances (59)
Healthcare (20862)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (139)
Indications (30)
Infectious disease (3010)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (100)
Interviews (812)
IPO (17810)
IRA (48)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (551)
Leadership (23)
Legal (10101)
Liver cancer (81)
Lung cancer (338)
Lymphoma (157)
Machine learning (7)
Management (65)
Manufacturing (339)
MASH (73)
Medical device (14602)
Medtech (14607)
Mergers & acquisitions (22427)
Metabolic disorders (756)
Multiple sclerosis (85)
NASH (23)
Neurodegenerative disease (110)
Neuropsychiatric disorders (33)
Neuroscience (2079)
NextGen: Class of 2025 (7667)
Non-profit (5079)
Now hiring (40)
Obesity (405)
Opinion (273)
Ovarian cancer (78)
Pain (93)
Pancreatic cancer (86)
Parkinson's disease (156)
Partnered (23)
Patents (246)
Patient recruitment (114)
Peanut (51)
People (65233)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22633)
Phase II (31839)
Phase III (23985)
Pipeline (1224)
Policy (166)
Postmarket research (3551)
Preclinical (10213)
Press Release (72)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (267)
Rare diseases (419)
Real estate (7391)
Recruiting (75)
Regulatory (26733)
Reports (57)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (78)
Series A (141)
Series B (90)
Service/supplier (27)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (45)
The Weekly (82)
Vaccines (799)
Venture capitalists (44)
Weight loss (286)
Women's health (40)
Worklife (20)
Date
Today (169)
Last 7 days (890)
Last 30 days (2747)
Last 365 days (34760)
2025 (11140)
2024 (37556)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (60)
Alaska (7)
Arizona (265)
Arkansas (14)
Asia (50096)
Australia (8826)
California (6341)
Canada (2040)
China (555)
Colorado (279)
Connecticut (284)
Delaware (154)
Europe (114809)
Florida (928)
Georgia (214)
Hawaii (1)
Idaho (64)
Illinois (604)
India (29)
Indiana (321)
Iowa (12)
Japan (165)
Kansas (111)
Kentucky (25)
Louisiana (13)
Maine (67)
Maryland (952)
Massachusetts (4855)
Michigan (232)
Minnesota (414)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (26)
Nevada (65)
New Hampshire (67)
New Jersey (1793)
New Mexico (30)
New York (1793)
North Carolina (1113)
North Dakota (9)
Northern California (2719)
Ohio (211)
Oklahoma (15)
Oregon (46)
Pennsylvania (1408)
Puerto Rico (13)
Rhode Island (35)
South America (1652)
South Carolina (22)
South Dakota (1)
Southern California (2340)
Tennessee (102)
Texas (942)
United States (24270)
Utah (186)
Virginia (158)
Washington D.C. (66)
Washington State (592)
West Virginia (3)
Wisconsin (57)
845,018 Results for "tevogen bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio Announces 2025 Annual Meeting
April 28, 2025
·
2 min read
Press Releases
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
April 9, 2025
·
5 min read
Press Releases
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
April 18, 2025
·
4 min read
Press Releases
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
May 1, 2025
·
3 min read
Press Releases
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
March 11, 2025
·
5 min read
Press Releases
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
March 26, 2025
·
6 min read
Press Releases
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations
March 3, 2025
·
6 min read
Press Releases
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
April 30, 2025
·
1 min read
Press Releases
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
March 27, 2025
·
5 min read
Press Releases
Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
February 11, 2025
·
5 min read
1 of 84,502
Next
